A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

Name: A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy
Published: 2019
License: Public Domain

Suven Life Sciences Limited · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

narcolepsy

narcolepsy, suvn-g3031, narcolepsy with and without cataplexy, cataplexy, narcolepsy type 1, narcolepsy type 2, excessive daytime sleepiness (eds), histamine h3 receptor, samelisant, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

Related documents